Ofosu et al., 1988 - Google Patents
Further studies on the mechanisms for the antithrombotic effects of sulfated polysaccharides in rabbitsOfosu et al., 1988
- Document ID
- 7307185944836386978
- Author
- Ofosu F
- Fernandez F
- Anvari N
- Caranobe C
- Dol F
- Cadroy Y
- Petitou M
- Mardiguian J
- Sie P
- Boneu B
- Publication year
- Publication venue
- Thrombosis and haemostasis
External Links
Snippet
A recent study (Fernandez et al., Thromb. Haemostas. 1987; 57: 286-93) demonstrated that when rabbits were injected with the minimum weight of a variety of glycosaminoglycans required to inhibit tissue factor-induced thrombus formation by—80%, exogenous thrombin …
- 241000283973 Oryctolagus cuniculus 0 title abstract description 37
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Soeda et al. | Fibrinolytic and anticoagulant activities of highly sulfated fucoidan | |
| Mätzsch et al. | Effects of an enzymatically depolymerized heparin as compared with conventional heparin in healthy volunteers | |
| Ockelford et al. | Discordance between the anti-Xa activity and the antithrombotic activity of an ultra-low molecular weight heparin fraction | |
| Andersson et al. | Molecular weight dependency of the heparin potentiated inhibition of thrombin and activated factor X. Effect of heparin neutralization in plasma | |
| Merton et al. | Experimental studies on the relative efficacy of dermatan sulphate and heparin as antithrombotic agents | |
| Walenga et al. | Antithrombotic activity of a synthetic heparin pentasaccharide in a rabbit stasis thrombosis model using different thrombogenic challenges | |
| Hara et al. | DX-9065a, an orally active, specific inhibitor of factor Xa, inhibits thrombosis without affecting bleeding time in rats | |
| Pacheco et al. | Different antithrombotic mechanisms among glycosaminoglycans revealed with a new fucosylated chondroitin sulfate from an echinoderm | |
| AU734112C (en) | Dermatan disulfate, an inhibitor of thrombin generation and complement activation | |
| Ofosu et al. | Increased sulphation improves the anticoagulant activities of heparan sulphate and dermatan sulphate | |
| EP0497756B1 (en) | Antithrombotic composition | |
| Agnelli et al. | Sustained antithrombotic activity of hirudin after its plasma clearance: comparison with heparin | |
| Fernandez et al. | Catalysis of thrombin inhibition provides an index for estimating the antithrombotic potential of glycosaminoglycans in rabbits | |
| Beguin et al. | The mode of action of low molecular weight heparin preparation (PK10169) and two of its major components on thrombin generation in plasma | |
| Thomas et al. | The relative antithrombotic effectiveness of heparin, a low molecular weight heparin, and a pentasaccharide fragment in an animal model | |
| Wall et al. | Characterisation of the anticoagulant properties of a range of structurally diverse sulfated oligosaccharides | |
| Scully et al. | Anticoagulant and antiheparin activities of a pentosan polysulphate | |
| Ofosu et al. | Further studies on the mechanisms for the antithrombotic effects of sulfated polysaccharides in rabbits | |
| Schulman | Studies on the medical treatment of deep vein thrombosis | |
| Melo et al. | An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases | |
| Tollefsen et al. | Modulation of heparin cofactor II activity by histidine-rich glycoprotein and platelet factor 4. | |
| PL177218B1 (en) | Anticoagulant | |
| Ofosu et al. | Heparin with low affinity to antithrombin III inhibits the activation of prothrombin in normal plasma | |
| Scully et al. | The anticoagulant properties of mast cell product, chondroitin sulphate E | |
| Tanaka et al. | The effect of heparin on multiple organ failure and disseminated intravascular coagulation in a sepsis model |